Alliance Forms Drug Distribution Leader With RMB 15 Billion Market
This article was originally published in PharmAsia News
The Zhejiang Community Medical Service Community and Zhejiang Intmedic announced Mar. 30 the official launch of a strategic collaboration to form a pharmaceutical distribution organization with a combined market size exceeding RMB 15 billion
You may also be interested in...
Amgen had a good third quarter despite some COVID-19 impacts but did not shed any light on filing plans for two key late-stage programs nor provide any insight into Phase III asthma results for tezepelumab.
The company is narrowing its 2020 guidance, citing COVID-19’s unpredictability and its effects on Veklury’s sales.
The price of the antibody monotherapy for COVID-19 will be $1,250 per vial for wealthy countries. CEO David Ricks outlined the company's guidelines for pricing and distributing a limited supply.